2nd Joint EBOVAC1 & EBOVAC2 annual meeting
The second joint EBOVAC1 & EBOVAC2 annual meeting was held in Windsor on 14-16 November 2016. Over 100 participants from both consortia attended. It was the opportunity to share information on the progress and results of 2016 activities.
1st Joint EBOVAC1 & EBOVAC2 annual meeting
The first EBOVAC1 & EBOVAC2 annual meetings was held in Paris from 20th to 22th of January 2016 at Novotel Convention & Wellness, Roissy.
EBOVAC2 Kick-off meeting
The project kick-off meeting was held at the Biopark auditorium, Paris on the 12th of February 2015.
More than 50 participants attended with representatives from the whole consortium, IMI2 and invited participants.
EBOVAC1 and EBOVAC2 presented a poster entitled “Development of a prophylactic Ebola Vaccine using and heterologous prime-boost regimen” at Targeting Ebola, Paris, 28-29 May 2015.
To view the poster, please click here
EBOVAC2 coordinator, Rodolphe Thiebaut, made a presentation concerning accelerated development of Ebola vaccines. After explaining the context and the challenges, he presented the current development pipeline of vaccine trials and the limitations of existing methodogies. He concluded by outlining perspectives for the future of Ebola vaccine development.
Rodolphe Thiébaut, Ebovac2 coordinator © Ebovac2